{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:30:25Z","timestamp":1780421425061,"version":"3.54.1"},"reference-count":31,"publisher":"Impact Journals, LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"DOI":"10.18632\/aging.204948","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T14:01:32Z","timestamp":1691503292000},"source":"Crossref","is-referenced-by-count":4,"title":["Anhydroicaritin suppresses tumor progression via the PI3K\/AKT signaling pathway in hepatocellular carcinoma"],"prefix":"10.18632","author":[{"given":"Houhong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of General Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou 236800, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou 236800, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayun","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Cancer Radiotherapy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China (Anhui Provincial Cancer Hospital), Hefei 230031, Anhui, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Gong","sequence":"additional","affiliation":[{"name":"Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Affiliated Hangzhou First People\u2019s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,8,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma.","volume":"40","author":"Saborowski","year":"2022","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.cnc.2022.04.004","article-title":"Hepatocellular Carcinoma.","volume":"3","author":"Landrum","year":"2022","journal-title":"Crit Care Nurs Clin North Am"},{"key":"3","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/liv.15251","article-title":"Changing epidemiology of hepatocellular carcinoma in Asia.","volume":"4","author":"Gao","year":"2022","journal-title":"Liver Int"},{"key":"4","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.","volume":"7","author":"Vogel","year":"2022","journal-title":"J Hepatol"},{"key":"5","doi-asserted-by":"publisher","first-page":"109543","DOI":"10.1016\/j.biopha.2019.109543","article-title":"Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma.","volume":"12","author":"Yu","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.joim.2021.08.004","article-title":"Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition.","volume":"1","author":"Sun","year":"2021","journal-title":"J Integr Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13020-022-00645-0","article-title":"Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma.","volume":"1","author":"Zhang","year":"2022","journal-title":"Chin Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"e920310","DOI":"10.12659\/MSM.920310","article-title":"Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine.","volume":"2","author":"Li","year":"2020","journal-title":"Med Sci Monit"},{"key":"9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1142\/S0192415X20500093","article-title":"Integrating Network Pharmacology and Experimental Models to Investigate the Efficacy of Coptidis and Scutellaria Containing Huanglian Jiedu Decoction on Hepatocellular Carcinoma.","volume":"4","author":"Feng","year":"2020","journal-title":"Am J Chin Med"},{"key":"10","doi-asserted-by":"publisher","first-page":"8669993","DOI":"10.1155\/2022\/8669993","article-title":"andStudies on the Mechanisms of Chinese Medicine Formula (Yiqi Jianpi Jiedu Formula) in the Treatment of Hepatocellular Carcinoma.","volume":"202","author":"Peng","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12906-021-03425-9","article-title":"Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology.","volume":"2","author":"Lai","year":"2021","journal-title":"BMC Complement Med Ther"},{"key":"12","doi-asserted-by":"publisher","first-page":"4860268","DOI":"10.1155\/2019\/4860268","article-title":"Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.","volume":"201","author":"Li","year":"2019","journal-title":"Biomed Res Int"},{"key":"13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.apha.2019.10.004","article-title":"Pharmacological effects of icariin.","volume":"8","author":"Shi","year":"2020","journal-title":"Adv Pharmacol"},{"key":"14","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.2147\/DDDT.S310686","article-title":"Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review.","volume":"1","author":"Wu","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00198-017-4255-1","article-title":"The effect of icariin on bone metabolism and its potential clinical application.","volume":"2","author":"Peng","year":"2018","journal-title":"Osteoporos Int"},{"key":"16","volume-title":"Use of icariin and epimedium flavonoids containing icariin to treat diseases associated with myelin sheath lesion.","author":"Lin","year":"2015"},{"key":"17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1871520616666160404111210","article-title":"Synthesis of Icaritin and \u03b2-anhydroicaritin Mannich Base Derivatives and Their Cytotoxic Activities on Three Human Cancer Cell Lines.","volume":"1","author":"Wang","year":"2017","journal-title":"Anticancer Agents Med Chem"},{"key":"18","doi-asserted-by":"publisher","first-page":"113984","DOI":"10.1016\/j.jpba.2021.113984","article-title":"Comparative analysis of chemical components in different parts of Epimedium Herb.","volume":"19","author":"Ma","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"19","doi-asserted-by":"publisher","first-page":"764481","DOI":"10.3389\/fcell.2021.764481","article-title":"Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis.","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"20","doi-asserted-by":"publisher","first-page":"115326","DOI":"10.1016\/j.jep.2022.115326","article-title":"Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: Coupling network pharmacology with experimental validation.","volume":"29","author":"Liu","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"21","doi-asserted-by":"publisher","first-page":"17109","DOI":"10.1038\/nplants.2017.109","article-title":"Demystifying traditional herbal medicine with modern approach.","volume":"3","author":"Weng","year":"2017","journal-title":"Nat Plants"},{"key":"22","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.19540\/j.cnki.cjcmm.20210502.102","article-title":"[Strategies for efficacy and function positioning of new resources of Chinese materia medica].","volume":"4","author":"Yang","year":"2021","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular Carcinoma: New Developments.","volume":"2","author":"Kulik","year":"2023","journal-title":"Clin Liver Dis"},{"key":"24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3389\/fphar.2019.01185","article-title":"Integrating Network Pharmacology and Pharmacological Evaluation for Deciphering the Action Mechanism of Herbal Formula Zuojin Pill in Suppressing Hepatocellular Carcinoma.","volume":"1","author":"Feng","year":"2019","journal-title":"Front Pharmacol"},{"key":"25","doi-asserted-by":"publisher","first-page":"153575","DOI":"10.1016\/j.phymed.2021.153575","article-title":"Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT\/CyclinD1\/p21\/p27 pathway.","volume":"8","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"26","doi-asserted-by":"publisher","first-page":"152930","DOI":"10.1016\/j.phymed.2019.152930","article-title":"Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.","volume":"6","author":"Yang","year":"2019","journal-title":"Phytomedicine"},{"key":"27","doi-asserted-by":"publisher","first-page":"618522","DOI":"10.3389\/fphar.2021.618522","article-title":"Network Pharmacology and Pharmacological Evaluation Reveals the Mechanism of thein Suppressing Hepatocellular Carcinoma.","volume":"1","author":"Wu","year":"2021","journal-title":"Front Pharmacol"},{"key":"28","doi-asserted-by":"publisher","first-page":"9103","DOI":"10.18632\/aging.204388","article-title":"Exploring the mechanisms underlying the therapeutic effect of theherb pair on hepatocellular carcinoma using multilevel data integration and molecular docking.","volume":"1","author":"Gao","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.gene.2018.01.083","article-title":"Inhibition of hepatocellular carcinoma tumorigenesis by curcumin may be associated with CDKN1A and CTGF.","volume":"65","author":"Wu","year":"2018","journal-title":"Gene"},{"key":"30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ejphar.2011.02.005","article-title":"An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells.","volume":"65","author":"Wang","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejphar.2017.05.017","article-title":"Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice.","volume":"80","author":"Xu","year":"2017","journal-title":"Eur J Pharmacol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T14:01:38Z","timestamp":1691503298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,8]]},"references-count":31,"alternative-id":["204948"],"URL":"https:\/\/doi.org\/10.18632\/aging.204948","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,8]]}}}